Atlas Trials

Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer

Clinical trial NCT00928252 · COMPLETED

Trial details

NCT number
NCT00928252
Sponsor
Queen's Medical Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hormone Refractory Prostate Cancer
Start date
2009-06-01
Primary completion
2016-06-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.